Cannassure Therapeutics Ltd
TASE:CSURE
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
C
|
Cannassure Therapeutics Ltd
TASE:CSURE
|
IL |
|
B
|
Banque Cantonale de Geneve
SIX:BCGE
|
CH |
|
Goldgroup Mining Inc
F:55G0
|
CA |
|
Sabana Industrial Real Estate Investment Trust
SGX:M1GU
|
SG |
|
J
|
Juliens International Entertainment Group Co Ltd
TPEX:6595
|
TW |
|
Dear Cashmere Group Holding Co
OTC:DRCR
|
CN |
|
Enghouse Systems Ltd
TSX:ENGH
|
CA |
|
T
|
Tiscon AG
XBER:TIS
|
DE |
|
A
|
Alta Co
VN:ALT
|
VN |
|
Aduro Clean Technologies Inc
TSX:ACT
|
CA |
|
Lapine Co Ltd
TSE:8143
|
JP |
|
Cannagistics Inc
OTC:CNGT
|
US |
|
N
|
Nonthavej Hospital PCL
SET:NTV
|
TH |
|
P
|
Playtech PLC
SWB:PL8
|
IM |
|
C
|
Cargosol Logistics Ltd
BSE:543621
|
IN |
|
C
|
C3 Metals Inc
OTC:CUAUF
|
CA |
|
Bidstack Group PLC
F:HHRN
|
UK |
Bankruptcy Probability
Cannassure Therapeutics Ltd's probability of bankruptcy is Hidden . The solvency score is Hidden .
We take all the information about a company's solvency, such as how easily it can pay interest on outstanding debt, how much cash it has, the amount of debt, and more, and use it to estimate the probability of bankruptcy.
Solvency Ratios
Solvency Ratios Comparison
Cannassure Therapeutics Ltd Competitors
| Country | Company | Market Cap | D/E | D/A |
Interest Coverage |
Altman Z-Score |
Quick Ratio |
Current Ratio |
Cash Ratio |
||
|---|---|---|---|---|---|---|---|---|---|---|---|
| IL |
C
|
Cannassure Therapeutics Ltd
TASE:CSURE
|
44.9m ILS |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Eli Lilly and Co
NYSE:LLY
|
1.1T USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Johnson & Johnson
NYSE:JNJ
|
640B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| JP |
|
Hisamitsu Pharmaceutical Co Inc
TSE:4530
|
70.4T JPY |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Merck & Co Inc
NYSE:MRK
|
369.3B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| CH |
|
Roche Holding AG
SIX:ROG
|
248.4B CHF |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| CH |
|
Novartis AG
SIX:NOVN
|
236.9B CHF |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| UK |
|
AstraZeneca PLC
LSE:AZN
|
185.7B GBP |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| IE |
E
|
Endo International PLC
LSE:0Y5F
|
243.1B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| CA |
|
Nuvo Pharmaceuticals Inc
TSX:MRV
|
286.1B CAD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| DK |
|
Novo Nordisk A/S
CSE:NOVO B
|
1.3T DKK |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Cannassure Therapeutics Ltd's probability of bankruptcy is Hidden .
The probability of bankruptcy is estimated using credit risk models that assess financial health, debt levels, interest coverage, and other solvency indicators.
As of the latest report, Cannassure Therapeutics Ltd has total debt of 30.2m ILS. This includes both short-term (14m ILS) and long-term (16.2m ILS) debt.
You can find a full breakdown on its Balance Sheet.
